A. Description of the Advisory Firm All Blue Labs, a Delaware limited liability company, is a registered investment adviser with the SEC. All Blue Labs began operations in 2021. All Blue Labs, Inc. (“ABL Inc.”) is the principal owner of All Blue Labs. Brexton Pham is the Chief Executive Officer of ABL, Inc. B. Types of Advisory Services All Blue Labs’ clients are private investment funds (in such capacity, the Firm’s “Clients”) managed by unaffiliated third-parties (“General Partners”). All Blue Labs provides non- discretionary investment advisory services to its Clients pursuant to an Investment Management Agreement (the “Agreement”). Pursuant to each fund’s offering memorandum, limited partnership agreement, and subscription documents, as applicable, (“Constituent Documents”), the funds offer limited partnership interests (“Interests”) to certain qualified investors as summarized in response to Item 7 below (such investors are referred to herein as “Investors”). In their capacity as offering Interests and making investments, All Blue Labs’ Clients are referred to herein as “Funds.” All Blue Labs services include originating and recommending investment opportunities; identifying sources of capital for, and structuring, monitoring and evaluating, investments; recommending the manner and timing of dispositions of investments and providing such other services (including certain managerial and administrative services necessary

for the operation of the Fund) as the Client may reasonably request and/or are contemplated by the Agreement. In addition, All Blue Labs will also arrange for and coordinate the services of other professionals and consultants in a non-binding capacity. The management, policies and operations of the Funds are the responsibility of their General Partners and all decisions relating to Fund matters, including, without limitation, the acquisition, management and disposition of Investments, are made by the General Partners in accordance with the Funds’ Constituent Documents. All Blue Labs may engage one or more sub-advisors to perform investment advisory services for the Client. All sub-advisory fees are be borne by the Firm at no additional cost to the Client. C. Tailored Services and Investor Imposed Restrictions Advisory services are tailored to each Client and particularly to support each Fund’s investment objectives. All Blue Labs provides its services on a non-discretionary basis. Each Fund’s General Partner has the authority to select which and how many securities and other instruments to buy or sell without consultation with the Funds or their Investors. D. Wrap Fee Programs All Blue Labs does not participate in wrap fee programs. E. Amounts Under Management As of December 31, 2022, All Blue Labs has $0 of regulatory assets under management on a discretionary basis and $4,300,000 on a non-discretionary basis.